# Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors

> **NCT01679470** · NA · TERMINATED · sponsor: **Nanospectra Biosciences, Inc.** · enrollment: 1 (actual)

## Conditions studied

- Primary or Metastatic Lung Tumors

## Interventions

- **DEVICE:** AuroLase Therapy

## Key facts

- **NCT ID:** NCT01679470
- **Lead sponsor:** Nanospectra Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01679470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01679470, "Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01679470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*